MedTrace Logo

Innovative Treatments in Pneumonia (ITIP) 3

NCT02960919 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1001

Last updated 2021-02-21

No results posted yet for this study

Summary

This is a prospective observational study assessing the clinical outcomes of children 2 to 59 months of age with both pneumonia and other co-morbidities presenting to a tertiary hospital outpatient setting in Malawi, Africa who are most at risk for mortality or have other complications and thus, are typically excluded from childhood pneumonia studies.

Conditions

Interventions

DRUG

oral amoxicillin or parenteral ampicillin/ penicillin and gentamicin

DRUG

parenteral ampicillin/ penicillin

DRUG

gentamicin

Sponsors & Collaborators

  • University of Washington

    collaborator OTHER

  • University of North Carolina

    collaborator OTHER

  • Kamuzu Central Hospital

    collaborator OTHER

  • Kamuzu University of Health Sciences

    collaborator OTHER

  • Save the Children

    lead OTHER

Principal Investigators

  • Amy Ginsburg, MD MPH · Save the Children, Federation Inc

Eligibility

Min Age
2 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-19
Primary Completion
2018-06-30
Completion
2018-07-31

Countries

  • Malawi

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02960919 on ClinicalTrials.gov